Followers | 57 |
Posts | 5853 |
Boards Moderated | 0 |
Alias Born | 08/12/2017 |
Tuesday, October 15, 2019 6:56:31 PM
As far as a buyout, there's not much doubt one will appear very soon, because there's no other biotech out there with 100,000,000 plus in revenues and valued at .03 a share, which is absolutely dirt cheap. I'm predicting a buyout of Arrayit before Christmas, or at least a couple of lookers, because it's a cash cow, and every suitor is searching for cash cows, that they can bleed to death and move on down the road, or continue the technological developments and move into Nasdaq under their umbrella..
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM